Caladrius Biosciences Strikes Deal With Japanese Regulators On Development Plan For Cell Therapy
April 18, 2016 at 08:52 AM EDT
Caladrius Biosciences Inc (NASDAQ: CLBS) disclosed that it struck a deal with the Japanese Pharmaceutical and Medical Devices Agency ...